We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
350 hedge funds and large institutions have $3.2B invested in Corcept Therapeutics in 2026 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 113 increasing their positions, 127 reducing their positions, and 100 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more capital invested
Capital invested by funds: $2.67B → $3.2B (+$535M)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
2.02% more ownership
Funds ownership: 72.79% → 74.8% (+2%)
10% less funds holding
Funds holding: 389 → 350 (-39)
11% less repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 127
31% less first-time investments, than exits
New positions opened: 69 | Existing positions closed: 100
50% less call options, than puts
Call options by funds: $49.6M | Put options by funds: $99.1M
Holders
350
Holders Change
-39
Holders Change %
-10.03%
% of All Funds
4.31%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.09%
New
69
Increased
113
Reduced
127
Closed
100
Calls
$49.6M
Puts
$99.1M
Net Calls
-$49.5M
Net Calls Change
+$80.7M
Top Buyers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$55.3M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$50.2M |
| 3 |
D.E. Shaw & Co
New York
|
+$37.8M |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$36.9M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$35.5M |
Top Sellers
| 1 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$34.6M |
| 2 |
EIP
Epoch Investment Partners
New York
|
-$28.4M |
| 3 |
JP Morgan Chase
New York
|
-$23.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$22.8M |
| 5 |
Morgan Stanley
New York
|
-$21.4M |
